Anli Ouyang1, Shang-Tian Yang. 1. Eli Lilly and Company, Bioprocess Research and Development, Lilly Corporate Center, DC 3945, Indianapolis, IN 46285, USA.
Abstract
BACKGROUND: Embryonic stem cells (ESCs) have unlimited proliferation potential and can differentiate into all cell and tissue types, and thus are ideal sources for cell therapy and drug screening. Current supplies of ESCs are limited by the available cell sources and inefficient culture methods that grow ESCs on surfaces coated with expensive extracellular matrix (ECM) proteins and in media containing expensive growth factors. OBJECTIVE: To meet the demand for ESCs, it is necessary to develop an economical process for their mass production. METHODS: We review the latest development in in vitro ESC culture and introduce a two-stage perfusion bioreactor system that uses 3-D fibrous matrices and conditioned media for production of ESCs. RESULTS/ CONCLUSION: The two-stage process can produce billions of ESCs in a small bioreactor without using ECM proteins and growth factors, and is promising for further scale-up for clinical applications.
BACKGROUND: Embryonic stem cells (ESCs) have unlimited proliferation potential and can differentiate into all cell and tissue types, and thus are ideal sources for cell therapy and drug screening. Current supplies of ESCs are limited by the available cell sources and inefficient culture methods that grow ESCs on surfaces coated with expensive extracellular matrix (ECM) proteins and in media containing expensive growth factors. OBJECTIVE: To meet the demand for ESCs, it is necessary to develop an economical process for their mass production. METHODS: We review the latest development in in vitro ESC culture and introduce a two-stage perfusion bioreactor system that uses 3-D fibrous matrices and conditioned media for production of ESCs. RESULTS/ CONCLUSION: The two-stage process can produce billions of ESCs in a small bioreactor without using ECM proteins and growth factors, and is promising for further scale-up for clinical applications.
Authors: Jörg C Gerlach; Mariah Hout; Josefina Edsbagge; Petter Björquist; Marc Lübberstedt; Toshio Miki; Harald Stachelscheid; Eva Schmelzer; Gerald Schatten; Katrin Zeilinger Journal: Tissue Eng Part C Methods Date: 2010-02 Impact factor: 3.056
Authors: Jörg C Gerlach; Marc Lübberstedt; Josefina Edsbagge; Alexander Ring; Mariah Hout; Matt Baun; Ingrid Rossberg; Fanny Knöspel; Grant Peters; Klaus Eckert; Annika Wulf-Goldenberg; Petter Björquist; Harald Stachelscheid; Thomas Urbaniak; Gerald Schatten; Toshio Miki; Eva Schmelzer; Katrin Zeilinger Journal: Cells Tissues Organs Date: 2010-02-27 Impact factor: 2.481
Authors: Michael P Storm; Craig B Orchard; Heather K Bone; Julian B Chaudhuri; Melanie J Welham Journal: Biotechnol Bioeng Date: 2010-11-01 Impact factor: 4.530
Authors: Michael P Storm; Ian Sorrell; Rebecca Shipley; Sophie Regan; Kim A Luetchford; Jean Sathish; Steven Webb; Marianne J Ellis Journal: J Vis Exp Date: 2016-05-26 Impact factor: 1.355